primary prevention

Should we all be taking the cholesterol-lowering drugs known as statins? Even if one has never had a heart attack or stroke, should they be on a statin for so-called primary prevention? The USPSTF has reviewed the data and answers with a qualified "yes."
A debate is on over the benefits of taking aspirin for those without a history of prior cardiovascular disease. The current thinking advocates using low-dose aspirin, for primary prevention, in certain high risk groups: those with advanced age, diabetes, high cholesterol, high blood pressure and smoking. But not so, says a new study from Japan. 
The current JAMA s Clinical Evidence Synopsis, and an accompanying editorial, strongly suggest